<?xml version="1.0" encoding="UTF-8"?>
<document id="29768408">
	<sentence id="s1" text="Here, we identified three families with mutations in ADD3, encoding for adducin-Î³, with intellectual disability, microcephaly, cataracts and skeletal defects.">
		<entity id="s1.e1" charOffset="53-57"
			type="GENE" text="ADD3" ontology_id="120"/>
		<entity id="s1.e2" charOffset="88-111"
			type="HP" text="intellectual disability" ontology_id="HP_0001249"/>
		<entity id="s1.e3" charOffset="113-125"
			type="HP" text="microcephaly" ontology_id="HP_0000252"/>
		<entity id="s1.e4" charOffset="127-136"
			type="HP" text="cataracts" ontology_id="HP_0000518"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
		<pair id="s1.p2" e1="s1.e1"
		    e2="s1.e3" pgr="true"/>
		<pair id="s1.p3" e1="s1.e1"
		    e2="s1.e4" pgr="false"/>
	</sentence>
	<sentence id="s2" text="In one of the families with additional cardiomyopathy and steroid-resistant nephrotic syndrome (SRNS), we found a homozygous variant in KAT2B, encoding the lysine acetyltransferase 2B, with impact on KAT2B protein levels in patient fibroblasts, suggesting that this second mutation might contribute to the increased disease spectrum.">
		<entity id="s2.e1" charOffset="39-53"
			type="HP" text="cardiomyopathy" ontology_id="HP_0001638"/>
		<entity id="s2.e2" charOffset="136-141"
			type="GENE" text="KAT2B" ontology_id="8850"/>
		<entity id="s2.e3" charOffset="190-196"
			type="GENE" text="impact" ontology_id="55364"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
		<pair id="s2.p2" e1="s2.e1"
		    e2="s2.e3" pgr="false"/>
	</sentence>
</document>
